Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer

BACKGROUND: In recent years, maintenance chemotherapy is increasingly being recognized as a new treatment strategy to improve the outcome of advanced non-small cell lung cancer (NSCLC). However, the optimal maintenance strategy is still controversial. Gemcitabine is a promising candidate for single-...

Descripción completa

Detalles Bibliográficos
Autores principales: Minami, Seigo, Kijima, Takashi, Shiroyama, Takayuki, Okafuji, Kohei, Hirashima, Tomonori, Uchida, Junji, Imamura, Fumio, Osaki, Tadashi, Nakatani, Takeshi, Ogata, Yoshitaka, Yamamoto, Suguru, Namba, Yoshinobu, Otsuka, Tomoyuki, Tachibana, Isao, Komuta, Kiyoshi, Kawase, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549766/
https://www.ncbi.nlm.nih.gov/pubmed/23281805
http://dx.doi.org/10.1186/1756-0500-6-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549766/
https://www.ncbi.nlm.nih.gov/pubmed/23281805
http://dx.doi.org/10.1186/1756-0500-6-3

Ejemplares similares